Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.6379 | 98 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 10.6666 | 98 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 10.3015 | 98 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.6598 | 98 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.3058 | 98 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 9.70805 | 98 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 9.86509 | 98 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 9.86098 | 98 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 9.73115 | 98 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.3433 | 98 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 10.8879 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.5751 | 98 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 10.6927 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.4861 | 98 |